YamamotoR,OkamotoK,YukiharuT,KaneuchiM,NegishiH,SakuragiN, 2001.A study of risk factors for ovarian metastases in stage IB-IIIB cervical carcinoma and analysis of ovarian function after a transposition,Gynecol Oncol 82 312 -6
PinsMR,YoungRH,DalyWJ,ScullyRE, 1996.Primary squamous cell carcinoma of the ovary: report of 37 cases,Am J Surg Pathol 20 823 -33
McCluggageWG, 2011.Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis,Pathology 43 420 -32
YemelyanovaA,JiH,ShihIeM,WangTL,WuLS,RonnettBM, 2009.Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases,Am J Surg Pathol 33 1504 -14
RobertsDE,LombardCM, 2013.Serous carcinoma of the ovary with squamous differentiation: a case report and a literature review,Int J Gynecol Pathol 32 459 -63
KovalevS,MarchenkoND,GugliottaBG,ChalasE,ChumasJ,MollUM, 1998.Loss of p53 function in uterine papillary serous carcinoma,Hum Pathol 29 613 -9
KwasniewskiW,GrywalskaE,ZdunekM,KorobowiczE, 2011.Estrogen and progesterone receptor expression in HPV positive and HPV-negative cervical carcinomas,Oncol Rep 26 153 -60
WangTY,ChenBF,YangYC,ChenH,WangY,CvikoA, 2001.Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases,Hum Pathol 32 479 -86
WuHS,YenMS,LaiCR,NgHT, 1997.Ovarian metastasis from cervical carcinoma,Int J Gynaecol Obstet 57 173 -8
MarusykA,PolyakK., 1805.Tumor heterogeneity: Causes and consequences",Rev Cancer 105 -17